In 2015, Ms. Campbell was appointed by Massachusetts Governor Charlie Baker to the Drug Formulary Commission.
Ms. Campbell has worked in the life sciences industry for 14 years as a pharmacologist, clinical research scientist and program manager. While attending law school, she worked at AstraZeneca where she developed molecular and cellular assays to identify candidate small molecules for the treatment of various cancers. In this role, Ms. Campbell managed multiple project teams to deliver candidate cancer drugs into Phase I clinical trials.
Following law school, Ms. Campbell served as the Program Manager for Regulatory Development at the Bureau of Health Care Safety and Quality with the MA Department of Public Health where she managed the promulgation of regulations affecting drug control, prescription monitoring and the pharmaceutical code of conduct in the Commonwealth. She also managed operations for the MA Drug Control and Prescription Monitoring Programs.
Prior to joining Goodwin, she was In-House Counsel at New England Research Institutes, Inc., (NERI) a contract research organization where she developed and negotiated clinical trial agreements and various commercial contracts while also leading the company’s business development efforts. While at NERI, she also attended the Massachusetts Institute of Technology Sloan School of Management where she participated in launching several startups while earning her M.B.A.
Ms. Campbell is a member of the Boston Bar Association, American Intellectual Property Law Association, the Boston chapter of the Healthcare Businesswomen’s Association and Women in Bio.